Ulrich Rodeck
11Patents
5h-index
10Co-inventors
63Inventor score
Filing activity: Apr 24, 1990 → May 13, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5470571A | Method of treating human EGF receptor-expressing gliomas using radiolabeled EGF receptor-specific MAB 425 | Chemistry; Metallurgy | 47 | Expired |
| US5622835A | WT1 monoclonal antibodies | Emerging Cross-Sectional Technologies | 25 | Expired |
| US5633142A | WT1 monoclonal antibodies and methods of use therefor | Emerging Cross-Sectional Technologies | 23 | Expired |
| US8895702B2 | Development of masked therapeutic antibodies to limit off-target effects; application to anti-EGFR antibodies | Chemistry; Metallurgy | 19 | Active |
| US10357571B2 | Development of masked therapeutic antibodies to limit off-target effects | Chemistry; Metallurgy | 13 | Active |
| US10414814B2 | Tumor-selective CTLA-4 antagonists | Chemistry; Metallurgy | 2 | Active |
| US10689423B2 | CTLA4-binding protein peptide-linker masks | Chemistry; Metallurgy | 1 | Active |
| US11311622B2 | Development of masked therapeutic antibodies to limit off-target effects | Chemistry; Metallurgy | 0 | Active |
| US11926652B2 | CTLA4-binding protein peptide-linker masks | Chemistry; Metallurgy | 0 | Active |
| US11279752B2 | Tumor-selective CTLA-4 antagonists | Chemistry; Metallurgy | 0 | Active |
| US11186642B2 | Development of masked therapeutic antibodies to limit off-target effects: application to anti-EGFR antibodies | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.